Author name: invadmin

Authority for determining material events and making disclosures in relation to Regulation 30(5) of the Listing Regulations

Appointment of Mr. Brijesh Kumar as Company Secretary, Compliance Officer and Key Managerial Personnel of the Company wef January 31,

Retirement of Mr. Ramjee Dorai as Company Secretary and Compliance Officer of the Company wef January 31, 2025.

Allotment of 1651 Equity Shares pursuant to the Employee Stock Option Scheme (ESOS) of the Company

Grant of options under Thyrocare Employees Stock Option Scheme

Intimation of allotment of equity shares of the Company under “Thyrocare Employee Stock Option Scheme”.

Equity Infusion In Thyrocare Laboratories (Tanzania) Limited

Appointment of Mr. Amey Joshi as Vice President – Human Resources

News Paper Publication

Completion Of Business Transfer Agreement With Vimta Labs Limited

Closure of Trading Window

Cessation of Independent Director

Press Release “Thyrocare Technologies Limited enters into a Business Transfer Agreement to acquire diagnostic and pathological services business of Vimta

Execution Of Business Transfer Agreement With Vimta Labs Limited.

Cessation of Independent Director

Completion of Business Transfer Agreement with Polo Labs Private Limited.

Execution of Business Transfer Agreement with Polo Labs Private Limited

Rectification Order Passed By The Income Tax Department, Mumbai For The Financial Year 2016-17

Completion of acquisition of Think Health Diagnostic Private Limited

Rectification of assessment order passed by the Navi Mumbai Municipal Corporation, Cess Department

Appointment Of Mr. Nitin Chugh As Chief Commercial Officer Of The Company W.E.F. February 22, 2024

Announcement under Regulation 30 (LODR)-Acquisition

Appointment of Mr. Rahul Guha, Managing Director and Chief Executive Officer of the Company as President – Operations and designated

Closure of Trading window 

Meeting with Investors/Analysts

Intimation under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

Meeting with Investors/Analysts

Reg30 Disc of Assesssment Order Navi Mumbai Muncipal Corporation

Closure of Trading window 

Entered into a Subscription Agreement at Tanzania

Meeting with Investors/Analysts

Proceedings of Annual General Meeting

Advertisement Notice for Thyrocare’s Annual General Meeting

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Intimation under Regulation 30 and Regulation 30A in the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Investor call intimation

Meeting with Investors/Analysts

Newspaper Publication

Closure of Trading Window

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Announcement under Regulation 30 (LODR)-Resignation of Director

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Closure of Trading window 

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Closure of Trading window 

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Corporate presentation for roadshow

Investment in LLP

Meeting with Investors/Analysts

Schedule Of Analysts/Institutional Investor Meet/Con. Call

Intimation of Board Meeting to be held on Friday 11, November , 2022 inter alia, to consider and approve the

Intimation that Trading Window shall remain closed for Directors / Designated Employees / Connected Persons with effect from 01 October

Schedule Of Analysts/Institutional Investor Meet/Con. Call

Intimation of allotment of 26,711 Equity Shares pursuant to exercise of ESOPs under ESOP Scheme 2019 

Schedule Of Analysts/Institutional Investor Meet/Con. Call      

Transcript of Earnings Call held on 02-08-2022

22nd Annual General Meeting – Proceedings.

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing copies of newspaper

Presentation on Audited Financial Results for the quarter ended June 30, 2022.

Intimation of decision taken at the Board Meeting held on August 01, 2022- (i) approval of the Unaudited Financial Results

Intimation about conference call for Indian and Overseas Investors to be held on Tuesday, August 02, 2022  to discuss about

Intimation of Board Meeting to be held on Monday 01, August, 2022 inter alia, to consider and approve the unaudited

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the copy of

Pursuant to the provisions of Section 91 of the Act, the Register of Members and Share Transfer Books of the

Intimation about 22nd   Annual General Meeting will be on Wednesday, August 03, 2022 at 4.00 P.M. at the Corporate office

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from July 01, 2022,

Transcript of Earnings Call held on 06-05-2022

Mr. Rahul Guha has taken charge as the Managing Director & Chief Executive Officer with effect from Wednesday, May 04,

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a conference

We wish to intimate that a conference call for the Indian and overseas analysts is arranged by our management to

Presentation on Audited Financial Results for the quarter / whole year ended 31-03-2022InvestorsPresentation31032022

Intimation of decisions taken at the Board Meeting held on April 29, 2022, about approved the Audited Financial Results (Stand-alone

Intimation about Board Meeting scheduled to be held on Friday, April 29 ,2022 inter alia, to consider and approve the

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from April 01, 2022,

Pursuant to Regulation 30 and Regulation 31(8)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you

Presentation – Unaudited financial results for the quarter/nine months period ended 31-12-2021.https://investor.thyrocare.com/wp-content/uploads/2022/03/Presentationupdate.pdf

Intimation of decision taken at the Board Meeting held on February 12, 2022 to approved the unaudited Financial Results (Stand-alone

The Board of Directors have, in order to comply with the provisions of Sub-Section 4 of Section 203 of the

Intimation about Board Meeting scheduled to be held on Saturday, February 12,2022 inter alia, to consider and approve the unaudited

Press Release being issued by the Company for the appointment of Mr. Rahul Guha as the Managing Director & Chief

The Board of Directors of the Company, at their meeting held on Saturday, 05th February, 2022, have approved appointment of 

The Board of Directors of the Company, at their meeting held on January 28, 2022, based on the recommendations of

Intimation of decision taken at the Board Meeting held on January 28, 2022 to approve the following Special Purpose Interim

Intimation of decision taken at the Board Meeting held on January 10, 2022 for approval for sharing financials statements for

Intimation of decision taken at the Board Meeting held on December 16, 2021 for approval for sharing certain financial information

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1st January, 2022

Intimation of decision taken at the Board Meeting held on November 13, 2021- (i) approval of the Unaudited Financial Results

Intimation about Board Meeting scheduled to be held on Saturday, November 13, 2021, inter alia, to consider and approve the

Intimation regarding allotment of 28913 Equity Shares to 158 eligible employees after obtaining required approvals from Stock Exchanges.

The Board of Directors of the Company, at their meeting held on 27th October 2021 has- 1)  Approved the Audited

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1st October, 2021

Intimation of decision taken at the Board Meeting held on August 12, 2021- (i) approval of the Unaudited Financial Results

Intimation about Board Meeting scheduled to be held on Thursday, August 12, 2021, inter alia, to consider and approve the

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1st July, 2021

Intimation about execution of a share purchase agreement dated 25 June 2021 between members of the promoter and promoter group

Intimation about (i) 21st  Annual General Meeting convened to be held on Saturday, June 26, 2021 at 3.00 P.M. through

Intimation of decisions taken at the Board Meeting held on May 8, 2021, about approval of the Audited Financial Statements

Intimation about Board Meeting scheduled to be held on Saturday, May 8, 2021, inter alia, to consider and approve the

Intimation of business update about increased turnover in Q4, enhancement on the RT-PCR testing capacity of laboratories at Navi Mumbai

Intimation that Trading Window shall remain closed for Directors / Designated Employees / Connected Persons with effect from 1st April,

Intimation about the Con-call with the representative(s) of First State Sentier, at 09.00 A.M. on Monday, March 08, 2021.

Intimation about Transcript of the Earnings Call held on Thursday, February 04, 2021 at 05.00 P.M. local time of Indian

Intimation about the con-calls with the representatives of the following organizations: (i) Mirabilis Investment Trust, at 05.00 P.M. on Monday,

Intimation about conference call for Indian and Overseas Investors to be held on Thursday, February 04, 2021 to discuss about

Intimation of outcome of the Board Meeting held on January 30, 2021, as follows: 1) The Board approved Unaudited Financial

Intimation about Board Meeting scheduled to be held on Saturday, January 30, 2021, inter alia, to consider and approve the

Intimation about (1) significant business revival in Q3 of the current financial year, after business activities resumed across all states,

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1st January, 2021

Intimation regarding allotment of 38054 Equity Shares to 135 eligible employees after obtaining required approvals from Stock Exchanges.

Intimation about the Con-call with the representative(s) of Grandeur Peak Global Advisors, at 10.00 A.M. on Tuesday, December 08, 2020.

Intimation about the Con-call with the representative(s) of Wellington Management Hong Kong Ltd., at 11.30 A.M. on Tuesday, November 24,

Intimation about the Con-call (Zoom Meeting) with the representative(s) of Arisaig Partners, at 05.00 P.M. today, i.e. on Tuesday, November

Intimation about Transcript of the Earnings Call held on Tuesday, November 03, 2020 at 12.00 Noon local time of Indian

Intimation about conference call for Indian and Overseas Investors to be held on Tuesday, November 03, 2020 to discuss about

Intimation of outcome of the Board Meeting held on October 28, 2020, as follows: 1) The Board approved Unaudited Financial

Intimation about Board Meeting scheduled to be held on Wednesday, October 28, 2020, inter alia, to consider and approve the

Intimation regarding business update on COVID-19 RT-PCR tests and COVID Antibody tests as on September 30, 2020.  The Company has

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1st October, 2020

Intimation about the con-calls with the representatives of the following organizations: (i) Nomura Asset Management Singapore Ltd., at 11.00 A.M.

Intimation regarding appointment of Mr. Arindam Haldar as Chief Executive Officer (CEO) of the Company w.e.f. September 14, 2020. View

Intimation of decisions taken at the Board Meeting held on September 10, 2020, authorizing Dr. A. Velumani, Chairman & Managing

Intimation about the Con-call (Zoom Meeting) with the representative(s) of Arisaig Partners, at 05.30 P.M. on Thursday, September 10, 2020.

Intimation about (i) 20th Annual General Meeting convened to be held on Tuesday, September 29, 2020 at 3.00 P.M. through

Intimation about the Con-call with the representative(s) of Sylebra Capital Limited, at 11.30 A.M. on Monday, September 07, 2020.

Intimation about Board Meeting scheduled to be held on Thursday, September 10, 2020, inter alia, to discuss and decide about

Intimation of decisions taken at the Board Meeting held on July 31, 2020, about (i) approval of the Unaudited Financial

Intimation about Board Meeting scheduled to be held on Friday, July 31, 2020, inter alia, to consider and approve the

Intimation about completion of 1,00,000 COVID-19 RT PCR tests in 108 days by Thyrocare at affordable cost and at minimum

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1st July, 2020

Intimation of decisions taken at the Board Meeting held on May 23, 2020, about i) approval of the Audited Financial

Intimation about Board Meeting scheduled to be held on Saturday, May 23, 2020, inter alia, to consider and approve the

Intimation about temporary suspension of PET-CT Scanning Operations at selective Centres managed/operated by our wholly-owned subsidiary, Nueclear Healthcare Limited, as

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1st April, 2020

Intimation about the con-calls with the representatives of the following organisations to discuss the impact of COVID-19: (i) ICICI Prudential

Intimation about Con-call arranged by PhillipCapital (India) Pvt. Ltd. with Dr. A. Velumani, Chairman, Managing Director and CEO of our

Intimation about Con-call through Prabhudas Lilladher (P) Limited, on ‘Covid-19 and Diagnostics’, at 04.00 P.M., today i.e. Wednesday, March 18,

Intimation about meeting of representative(s) of Crescita Investment Management Pvt. Ltd. with us at 04.00 P.M. on Wednesday, March 11,

Intimation about the following forthcoming Analyst meetings: (i) Meeting with the representative(s) of J. P. Morgan India Private Limited, at

Intimation about the following forthcoming Analyst meetings: (i) Meeting with the representative(s) of QRC Investment Advisors LLP, at 11.30 A.M.

Press Release – Launching of marketing Joint Venture by Thyrocare for Datar Cancer Genetics, for early detection of 16 types

Intimation about the following forthcoming Con-call: (i) Con-call with the representative(s) of Eternity Capital Management Limited, at 11.00 A.M. on

Update about closure of two centres (Surat and Baroda) of Nueclear Healthcare Limited, wholly owned subsidiary of the Company.

Intimation of decisions taken at the Board Meeting held on February 01, 2020, about (i) approval of the Unaudited Financial

Intimation about Board Meeting scheduled to be held on Saturday, February 01, 2020 to inter alia, consider and approve the

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1st January 2020

Intimation that the Company has allotted 37,759 numbers of equity shares to 103 eligible employees of the Company, who have

Intimation about meeting of representative(s) of Sundaram Asset Management Company Limited, with us at 10.30 A.M. on Saturday, December 14,

Intimation about the following forthcoming Analyst meetings: (i) Meeting with the representative(s) of Banyan Capital Advisors LLP, at 11.30 A.M.

Intimation about the following forthcoming Con-call / Analyst meeting: (i) Con-call with the representative(s) of Nippon India Mutual Fund, at

Intimation about meeting of representative(s) of InvesQ Investment Advisors, with us at 11.00 A.M. on Friday, November 29, 2019 at

Intimation about the following forthcoming Con-call / Analyst meeting: (i) Con-call with the representative(s) of Eternity Capital Management Limited, at

Intimation about the following forthcoming Con-call / Analyst meeting: (i) Con-call with the representative(s) of Bajaj Allianz, Pune, at 04.00

Intimation of decisions taken at the Board Meeting held on November 07, 2019, about approval of the Unaudited Financial Results

Intimation about Board Meeting scheduled to be held on Thursday, November 07, 2019 to inter alia, consider and approve the

Intimation that  the representative(s) of Capital Investment Research Services Private Limited would be having a Con-call with us by 05.30

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1st October 2019

Intimation about the following forthcoming meeting / Con-call: (i) Con-call with the representative(s) of Sundaram Asset Management Company Limited, at

At their meeting held today, the Audit Committee reviewed the valuation reports of Nueclear Healthcare Ltd., (NHL) received from Karvy

Intimation about Board Meeting scheduled to be held on Saturday, September 21, 2019 to consider the report of valuation of

Intimation about the following forthcoming meetings: (i) Meeting with the representative(s) of Sunidhi Securities & Finance Limited, at 4.00 P.M.

Intimation that  the representative(s) of Angle Broking Limited would be having a Con-call with us by 11.00 A.M. on Monday,

Intimation about meeting of representative(s) of SAIF Partners, with us at 10.30 A.M. on Tuesday, August 27, 2019 at the

Intimation that Mr. Anand Velumani, Director, Nueclear Healthcare Limited, our wholly owned subsidiary, would be participating at the ‘15th Annual Global Investor Conference’

Intimation about conference call for Indian and Overseas Investors to be held on 14-08-2019 to discuss about Unaudited financial results

Intimation about the outcome of the Board Meeting held on 10-08-2019 (i) Approval of Unaudited financial results (Stand-alone and Consolidated)

Intimation about Board Meeting scheduled to be held on Saturday, August 10, 2019 to inter alia, consider and approve the

Intimation about (i) 19th Annual General Meeting convened to be held on 24-08-2019 at 3.00 P.M. at Hotel Yogi Midtown,

Intimation about meeting of representative(s) of Baring Private Equity Asia, with us at 3.30 P.M. on Friday, July 05, 2019,

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with immediate effect and will be

Intimation about the following forthcoming meetings: (i) Meeting with the representative(s) of PhillipCapital India Private Limited, at 3.30 P.M. on

Post-script of the conference call of Indian and Overseas Investors held on 21-05-2019 to discuss about audited financial results (stand-alone

Intimation about the following forthcoming meetings: (i) Meeting with the representative(s) of Securities Investment Management Pvt. Ltd., at 3.30 P.M.

Intimation that while considering the offer made by Dr. A. Velumani, Chairman, MD & CEO to acquire the Company’s shareholding

Intimation about the following forthcoming meetings: (i) Meeting with the representative(s) of Sundaram Mutual Fund, at 10.30 A.M. on Saturday,

Intimation that a meeting of the Board of Directors will be held on Thursday, June 13, 2019, to discuss about

Intimation about the following forthcoming meetings: i) Meeting with the representative(s) of CWC Advisors, at 02.00 P.M. on Tuesday, May

Intimation that  the representative(s) of SAIF Partners would be having a Con-call with us by 3.00 P.M. on Thursday, May

Intimation about meeting of representative(s) of Anived Portfolio Managers Private Limited, with us at 02.00 P.M. on Wednesday, May 22,

Intimation that we had participated in the tender floated by Municipal Corporation of Greater Mumbai (the “MCGM”) for outsourcing of

Intimation that at the Board Meeting held on 18-05-2019, when the Auditors pointed out the impairment of investment in Nueclear

Intimation about conference call for Indian and Overseas Investors to be held on 21-05-2019 to discuss about Audited financial results

Intimation of decisions taken at the Board Meeting held on May 18, 2019, about approval of the Audited Financial Statements

Intimation about Board Meeting scheduled to be held on Saturday, May 18, 2019 to inter alia, consider and approve the

Intimation about meeting of representative(s) of SAIF Partners, with us at 10.00 A.M. on Thursday, May 02, 2019 at the

Intimation that Trading Window shall remain closed for Directors, Employees and Connected Persons from April 26, 2019 until 48 hours

Confirmation of compliance of provisions of Reg. 74(5) of SEBI (Depositories & Participants) Regulations 2018, as certified by the Company’s

Intimation about non-applicability of framework for Fund Raising by issue of Debt Securities by Large Entities notified by SEBI

Intimation that representative(s) of TA Associates, would be having a meeting with us at 2.30 P.M. on Thursday, April 11, 2019

Intimation about the following analyst meetings to be held at our corporate office: i) Meeting with the representative(s) of Arisaig

Intimation about the following Analyst Meetings: i) Meeting with the representative(s) of Sands Capital Management, at 12.30 P.M. on Monday,

Intimation about the following Analyst Meetings : i) Meeting of the representative(s) of Way2Wealth, a Coffee Day Company, at 11.30

Intimation about the following Analyst Meetings / Con-call, to be held at our corporate office: i) Con-call between us and

Intimation about the outcome of the Board Meeting held on 09-03-2019 – Appointment of Dr. Indumati Gopinathan as an Independent

Intimation about the following analyst meetings to be held at our corporate office:  i) Meeting of the representative(s) of TA

Intimation about the following analyst meetings to be held at our corporate office:  i) Meeting of the representative(s) of Lohia

Post-script of the conference call of Indian and Overseas Investors held on 12-02-2019 to discuss about unaudited financial results (stand-alone

Intimation about the following analyst meetings to be held at our corporate office:  i) Meeting of the representative(s) of Consortium

Intimation that Ms. Alka Katiyar, Research Associate- Pharma Institutional Equities of IndiaNivesh Securities Limited would be having a meeting with

Intimation that Mr. Robert Harvey and Mr. Taizo Ishida, Portfolio Managers of Matthews Asia would be having a meeting with  Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde,Deputy  General Manager- Finance at Hotel Trident, BKC by 09.00 A.M. on Wednesday, December 05, 2018.

Intimation that Mr. Shrikant Akolkar, Senior Analyst- Pharma of IIFL Securities Limited would be having a meeting with Mr. Sachin Salvi,  General Manager-Finance, at our office by 11.00 A.M. on Tuesday, December 04, 2018.

Intimation that Ms. Charvi Pandey, Analyst of Fidelity International would be having a meeting with Mr. Sachin Salvi, General Manager-Finance,

Intimation that Mr. Kalpesh Parekh, Vice President- Institutional Sales and Mr. Surajit Pal, Analyst of Prabhudas Lilladher Pvt. Ltd. would

Intimation that Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde, Deputy General

Intimation that Mr. Navin Ramachandran, Fund Manager and Mr. V. Srinath, Senior Analyst of Bellwether Capital would be having a

Intimation that Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde, Deputy General

Post-script of the conference call of Indian and Overseas Investors held on 12-11-2018 to discuss about unaudited financial results (stand-alone

Intimation that Mr. Sachin Salvi, General Manager-Finance, would be participating at IDFC Securities Annual Investor Conference ‘The Stock called India’

Intimation about conference call for Indian and Overseas Investors to be held on 12-11-2018 to discuss about Unaudited financial results

Intimation about the outcome of the Board Meeting held on 03-11-2018 – Approval of unaudited financial results for the quarter/half

Intimation that Mr. Suney Hindocha and Mr. Edward Lam, Fund Managers of Somerset Capital Management, UK, would be having a

Intimation that Mr. Stephen Farley, Managing Partner and Mr. Andrei Stetsenko, Partner of Farley Capital, New York would be having

Intimation about Board Meeting scheduled to be held on November 03, 2018, to inter alia, consider and approve the unaudited

Intimation that Mr. Krishnakumar, CIO of Sundaram Mutual Fund would be having a con-call with our Chairman & Managing Director,

Intimation about meeting of Mr. Sunil Asnani, Portfolio Manager, of Matthews International Capital Management, with one or more of the

Intimation about participation of Mr.Anand Velumani, and Mr. Aditya Shinde, Deputy General Manager-Finance in the Investor Conference organised by Motilal

Intimation about meeting of Mr. Kalpraj Dharamshi, Promoter of Dharamshi Securities Private Limited & Valuequest Investment Advisors P.Ltd., with our

Intimation that Mr. Masahiro Kanezaki , Portfolio Manager of Portfolia Japan, who would meet our Chairman, Managing Director & CEO,

Intimation about meeting of Mr. Apurv Kulkarni, Senior Analyst of Nine Rivers Capital Holdings Pvt. Ltd., with Dr. Caesar Sengupta,

Post-script of the conference call of Indian and Overseas Investors held on 14-08-2018 to discuss about unaudited financial results (stand-alone

Intimation about meeting of Mr. A. N. Seshadri, Principal and Mr. Gaurav Kothari, Fund Manager of Nalanda Capital, with our

Intimation about meeting of Mr. Masahiro Kanezaki, Portfolio Manager of Portfolia Japan, a part of Maybank, Malaysia, with our Chairman,

Intimation about conference call of Indian and Overseas Investors to be held on 14-08-2018 to discuss about Unaudited financial results

Intimation about meetings of the following with our Chairman & Managing Director, Dr. A. Velumani, at our office tomorrow, 14th

Intimation about approval of the Unaudited Financial Statements (both Stand-alone and Consolidated) for the quarter ended 30-06-2018 at the Board

Intimation that the 18th Annual General Meeting (originally scheduled to be held on 11-08-2018) has been postponed to 01-09-2018 due

Intimation of Outcome of the Board Meeting held on August 04, 2018, (i. ) to approve a proposal of buy

Intimation about Board Meeting scheduled to be held on August 11, 2018, to inter alia, consider and approve the unaudited

Intimation about Board Meeting scheduled to be held on August 04, 2018, to consider the proposal of buy back of

Intimation about the meeting of Mr. Sudarshan Padmanabhan, Research Analyst-Investment, of Sundaram Asset Management Company Limited, with our Chairman &

Intimation about the meeting of Ms. Charulata Gaidhani and Mr. Milind Karmarkar, Research Analysts of Dalal & Broacha Stock Broking

Intimation about the meeting of Mr. Ashwin Reddy of Samatva Investments, with our General Manager-Finance, Mr. Sachin Salvi at our

Intimation about the meeting of Ms.Roopa Raman of International Finance Corporation (IFC), with our General Manger-Finance, Mr. Sachin Salvi and

Post-script of the conference call of Indian and Overseas Investors held on 03-05-2018 to discuss about audited financial results (stand-alone

Intimation about the meeting of Mr. Sandip Patodia, Equity Analyst of Fundsmith LLP, with our Chairman & Managing Director, Dr.

Intimation about meeting of Mr. Vinod Jayaram, Senior Investment Analyst, of Elara Capital, with our General Manager- Finance, Mr. Sachin

Intimation about conference call of Indian and Overseas Investors to be held on 03-05-2018 to discuss about Audited financial results

Intimation of decisions taken at the Board Meeting held on April 28, 2018, about approval of the Audited Financial Statements

Intimation about Board Meeting scheduled to be held on April 28, 2018, to approve Audited financial results (Stand-alone and Consolidated)

Intimation about meeting of Mr. Bharat Shah of ASK Wealth Management, with our Chairman & Managing Director, Dr. A. Velumani,

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani, with Mr. Nitin Bajaj of FIL India Business

Intimation about meeting of Mr. Kantor of Allard Partners, Hong Kong with Mr. Sachin Salvi, General Manager-Finance, by 9.00 A.M.

Post-script of the conference call of Indian and Overseas Investors held on 09-02-2018 to discuss about unaudited financial results (stand-alone

Intimation about conference call of Indian and Overseas Investors to be held on 09-02-2018 to discuss about unaudited financial results

Intimation of decisions taken at the Board Meeting held on February 03, 2018, about approval of the Unaudited Financial Statements

Intimation about Board Meeting scheduled to be held on February 03, 2018, to approve unaudited financial results (Stand-alone and Consolidated)

Post-script of the conference call of Indian and Overseas Investors held on 12-12-2017 to discuss about unaudited financial results (stand-alone

Intimation about conference call of Indian and Overseas Investors to be held on 12-12-2017 to discuss about unaudited financial results

Intimation of decisions taken at the Board Meeting held on December 09, 2017, about approval of the Unaudited Financial Statements

Intimation about Board Meeting scheduled to be held on December 09, 2017 to approve unaudited financial results (Stand-alone and Consolidated)

Intimation that Mr. Silas Xu, Founding Partner and Mr. Tushar Mallo, Partner of Ishana Capital, a newly formed long/short equity

Intimation about con-call arranged by Edelweiss between Mr. Arnab Nandi, Portfolio Manager of Oxbow Capital and our General Manager- Finance,

Intimation about meeting of analysts / representatives of different fund houses with Mr. Sachin Salvi,General Manager-Finance and/or Mr. Vatsal Goyal,

Intimation about meeting of analysts / representatives of different fund houses with Mr. Sachin Salvi, General Manager-Finance and Mr. Vatsal

Intimation about meeting of Mr. Rakesh Nayudu, Analyst- Healthcare, of Haitong Securities India Private Limited, and his team with Mr.

Intimation about participation of Mr.Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head – Strategy & Development, in the Investor

Intimation about change in the Board of Directors, i.e. appointment of Dr. Indumati Gopinathan as a Director in the place

Intimation about the post-quarterly results conference call scheduled to be held at 3.00 p.m. on Monday,21-08-2017.

An update of the 17th Annual General Meeting of the Company held on 12-08-2017 and the resolutions passed thereat.

Intimation about decisions taken at the Board Meeting held on August 12, 2017, about approval of the Unaudited Financial Statements

Intimation about Board Meeting scheduled to be held on August 12, 2017 to approve unaudited financial statements (both Stand-alone and

Intimation about notice received from a shareholder proposing appointment of Dr. Indumati Gopinathan as a Director in the place of

Intimation about 17th Annual General Meeting convened to be held on 12-08-2017 at 10.30 A.M. , Book-Closure for payment of

Intimation about meeting of Mr. Naveen Baid, Senior Analyst and Mr. Avinash Nahata, Head-Fundamental Equity Desk, of Aditya Birla Money

Intimation about meeting of: (i)Mr. Eric Jones, Portfolio Manager of Dragoneer Investment Group, U.S., with our Head (Strategy and Corporate

Intimation about: Meeting of Mr. H. Sangameswar Iyer, V.P. Investments, Shubhkam Ventures, with our General Manager-Finance, Mr. Sachin Salvi, and

Intimation about: Meeting of Mr. Lukas Davies, Barca Capital USA, with our Vice-President, Dr. Caesar Sengupta, General Manager-Finance, Mr. Sachin

Intimation about: Meeting of one Group of Investor with our Chairman & Managing Director, Dr. A. Velumani, by 10.00 A.M.,

Intimation that as the final dividend is subject to approval of members, the provision made therefor has been revised, resulting

Intimation about meetings of Mr. Sudarshan Padmanabhan, Analyst, Sundaram Mutual Fund, with our Vice-President, Dr. Caesar Sengupta, General Manager-Finance, Mr.

Intimation about Mr. Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head – Nueclear Operations, participating at an investor conference

Intimation about meeting of the representatives of various funds, as follows, with our Chairman & Managing Director, Dr. A. Velumani,

Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani, in an investor conference on 30th May, 2017

Intimation about conference call on 11-05-2017 about the Audited financial results for the quarter / whole year ended March 31,

Intimation about decisions taken at the Board Meeting held on May 09, 2017, about approval of the Audited Financial Statements

Intimation about Board Meeting scheduled to be held on May 09, 2017 to approve audited financial statements (both Stand-alone and

Intimation about meeting of the representatives of various funds, as follows, with our Chairman & Managing Director, Dr. A. Velumani,

Intimation about meeting of Mr. Mahesh Natarajan of ICICI Securities and Mr. Shriraam Rathi, ISec Healthcare Research Analyst, with our

Intimation about meeting of Mr. Anmol Ganjoo, of J M Financial, with our General Manager-Finance, Mr. Sachin Salvi at our

Intimation about meeting of Mr. Abhishek Thepade, Fund Manager of DNB Nor, with our General Manager-Finance, Mr. Sachin Salvi at

Intimation about the following decisions taken at the Board Meeting held on March 24, 2017, subject to approval of Members

Intimation about meeting of Mr. Rahul Gupta, Investment Analyst, of Fidelity International, with our General Manager-Finance, Mr. Sachin Salvi at

Intimation about change in timing of Conference Call between Mr. Anubhav Aggarwal, Healthcare Analyst from Credit Suisse and our General

Intimation about a Conference Call between Mr. Anubhav Aggarwal, Healthcare Analyst from Credit Suisse and our General Manager- Finance, Mr.

Intimation about meeting of Mr. Kahlil Randeria and his team from New Horizon Funds, India, with our Chairman & Managing

Intimation about meeting of Mr. Owens Huang, Asia Specialist & Co-Portfolio Manager from Dalton Investment, US, with our Vice-President (Operations),

Intimation about meeting of Mr. Anup Maheshwari, CIO & Head of Equities of DSP Blackrock, and his team, with our

Intimation about meeting of Mr. Dushyant Sahani, Associate, of Samena Capital Investments Limited, Dubai, with our Vice President (Operations) Dr.

Intimation about meeting of Mr. Atul Mehra, Senior Analyst, and Mr. Prateek, of Motilal Oswal Mutual Fund, with our General

Intimation about meeting of Mr. Balvinder Singh, Analyst from Canara HSBC, with our Vice-President (Operations), Dr. Caesar Sengupta and General

Intimation about conference call on 31-01-2017 about the unaudited financial results for the quarter / nine-months ended December 31, 2016.

Intimation of Outcome of the Board Meeting held on January 28, 2017 .(i) To declare an interim dividend of Rs. 5/-

Intimation about meeting of Mr. Jack and Mr. Mohan of Stewart Investors, UK, with our Chairman & Managing Director, Dr.

Intimation about Board Meeting scheduled to be held on January 28, 2017 to approve unaudited financial statements (both Stand-alone and

Intimation about meeting of our General Manager-Finance, Mr. Sachin Salvi, with Mr.Shaleen Kumar of UBS Securities India, at our office

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Ms. Amisha Vora & Mr. Dilip Bhat,

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Sandeep Kothari and Mr. Rahul Gupta,

Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani, in Spark Healthcare Conference 2016, in BKC, Mumbai

Intimation about meeting of our General Manager-Finance, Mr. Sachin Salvi, with Mr. Sarath Sathkumara, Managing Director, Taiyo Pacific Partners, USA,

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Arindam Bhattacharjee, Partner & Portfolio Manager,

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Sunil Asnani, Portfolio Manager of Matthews

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Krishna Kumar, Portfolio Manager of Eastsprings

Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani at the IDFC Annual Investor Conference at “The

Intimation about meeting of analysts from Stewart Investors, UK, with our Chairman & Managing Director, Dr. A. Velumani on 02-11-2016

Intimation about conference call on 25-10-2016 about the unaudited financial results for the quarter / half-year ended September 30, 2016.

Intimation about approval of the unaudited financial results – both Stand-alone and Consolidated – for the quarter / half-year ended

Intimation about Board Meeting scheduled to be held on October 24, 2016, to approve unaudited financial statements (both Stand-alone and

Intimation about meeting between a few investors / fund managers and our Chairman & Managing Director, Dr. A. Velumani, on

Intimation about meeting between analysts from Ventura Capital with our General Manager-Finance, Mr. Sachin Salvi on Wednesday, September 28, 2016

Intimation about meeting between a few analysts / fund managers and our Chairman & Managing Director, Dr. A. Velumani on

Intimation about the 16th Annual General Meeting held on September 12, 2016.

Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani in a conference organised by Nomura group in

Intimation about decision taken at the Board Meeting held on 27-08-2016 regarding sale of shares held by the Company in

Intimation about approval of the unaudited financial results – both Stand-alone and Consolidated – for the quarter ended June 30,

Intimation about Board Meeting scheduled to be held on July 22, 2016 to approve unaudited financial results (Stand-alone and Consolidated),

Intimation about Meeting of a few analysts / fund managers with our Chairman & Managing Director at the Company’s Corporate

Intimation about Conference call arranged by the Company on June 15, 2016 for Indian and Overseas Investors to discuss about

Intimation about decisions taken at the Board Meeting held on June 11, 2016, about approval of the Financial Statements (both

Intimation about Board Meeting scheduled to be held on June 11, 2016 to approve financial statements (both Stand-alone and Consolidated),

Intimation about Participation by the Company’s Chairman & Managing Director, Dr. A. Velumani in an Investors Conference organized by M/s.

Intimation about Plant visit by Analyst/Institutional Investor (Ambit Capital P. Ltd.) followed by one-to-one meeting on May 24, 2016.

Intimation about Plant visit by Analyst/Institutional Investor (Fidelity International) followed by one-to-one meeting on May 25, 2016. Latest Press Releases/Advertisements